Stockscreener 앱 받기
22.29
6.91%
-1.655
시간 외 거래:
22.49
0.205
+0.92%
전일 마감가:
$23.94
열려 있는:
$20
하루 거래량:
7.29M
Relative Volume:
5.81
시가총액:
$1.10B
수익:
$224.45M
순이익/손실:
$-95.27M
주가수익비율:
-11.55
EPS:
-1.93
순현금흐름:
$-43.74M
1주 성능:
-3.99%
1개월 성능:
-12.19%
6개월 성능:
+24.78%
1년 성능:
-4.48%
1일 변동 폭
$19.82
$22.59
1주일 범위
$19.82
$24.26
52주 변동 폭
$13.50
$30.81
Staar Surgical Co Stock (STAA) Company Profile
명칭
Staar Surgical Co
전화
(626) 303-7902
주소
1911 WALKER AVE, MONROVIA, CA
STAA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
22.29 | 1.18B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
592.85 | 200.78B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
205.36 | 56.69B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.81 | 39.62B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
249.19 | 35.81B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
39.77 | 30.70B | 27.43B | 1.27B | 1.01B | 1.5829 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Wells Fargo | Equal Weight |
| 2025-02-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-02-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-02-12 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2025-02-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-03-11 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-05 | 다운그레이드 | Needham | Buy → Hold |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-09-15 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | 개시 | Piper Sandler | Neutral |
| 2023-02-06 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-12-28 | 재확인 | BTIG Research | Buy |
| 2022-12-08 | 개시 | Stifel | Hold |
| 2022-11-07 | 업그레이드 | Sidoti | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-28 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-07-09 | 개시 | Oppenheimer | Perform |
| 2021-01-19 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-10-26 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-08-31 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-08-06 | 재확인 | The Benchmark Company | Buy |
| 2020-07-06 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-06-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-06-15 | 개시 | Jefferies | Buy |
| 2019-12-04 | 개시 | BTIG Research | Buy |
| 2018-09-24 | 재확인 | The Benchmark Company | Buy |
| 2018-08-06 | 재개 | The Benchmark Company | Buy |
| 2017-11-20 | 재확인 | The Benchmark Company | Buy |
| 2017-08-14 | 재확인 | The Benchmark Company | Buy |
| 2017-03-03 | 재확인 | The Benchmark Company | Buy |
| 2016-05-18 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2013-09-10 | 재개 | The Benchmark Company | Buy |
| 2013-02-28 | 재확인 | The Benchmark Company | Buy |
| 2012-11-01 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | 개시 | Northland Securities | Outperform |
| 2011-10-25 | 재확인 | The Benchmark Company | Buy |
| 2010-10-12 | 개시 | Morgan Joseph | Buy |
| 2010-05-11 | 개시 | Benchmark | Buy |
모두보기
Staar Surgical Co 주식(STAA)의 최신 뉴스
Alcon terminates merger agreement with STAAR Surgical By Investing.com - Investing.com South Africa
Alcon terminates merger agreement with STAAR Surgical - Investing.com
Staar Surgical to reject Alcon takeover bid after failing to win shareholder backing - Reuters
STAAR Surgical sinks as it plans to terminate sale to Alcon (update) (STAA:NASDAQ) - Seeking Alpha
Staar, Alcon Deal to Fizzle - Medical Device and Diagnostic industry
STAAR Surgical's proposed merger with Alcon falls through as shareholders reject the deal - Bitget
STAAR Surgical Merger With Alcon Fails After Shareholders Vote No - Benzinga
Staar Surgical Shareholders Reject $1.6 Billion Merger - Orange County Business Journal
Exclusive: STAAR Surgical deal fails as shareholder support remains at around 30% - Investing.com Canada
STAAR Surgical stock rating reiterated as Neutral by BTIG - Investing.com Nigeria
Alcon wishes on the wrong Staar as $1.6B merger rejected - BioWorld MedTech
Needham maintains Hold rating on STAAR Surgical stock after failed acquisition - Investing.com Nigeria
STAAR shareholders reject Alcon acquisition bid - Investing.com
STAAR Surgical (STAA) Shares Drop 19% After Alcon Deal Terminati - GuruFocus
STAAR shareholders reject Alcon acquisition bid By Investing.com - Investing.com UK
STAAR shareholders just rejected a proposed sale of the company to Alcon - Stock Titan
STAAR Surgical Says It Plans to Terminate Merger Deal with Alcon - Medical Product Outsourcing
Staar Surgical to terminate Alcon deal after stockholder vote - MassDevice
STAAR Surgical to remain independent after failed Alcon merger vote By Investing.com - Investing.com India
STAAR Surgical Co Announces Termination of Alcon Merger Agreement - TradingView — Track All Markets
STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders - Bluefield Daily Telegraph
STAAR Surgical (STAA) Faces Potential Delay in Alcon (ALC) Acqui - GuruFocus
STAAR Surgical vote on Alcon may be delayed againreport - Seeking Alpha
Is STAAR Surgical Company a good long term investmentDividend Growth Stocks & Breakthrough Stock Performance - earlytimes.in
The Truth About STAAR Surgical Co: Tiny Eye Stock With Massive Upgrade Energy - AD HOC NEWS
Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal
New $17 Million Bet on STAAR Surgical Comes as Sales Jump 7% and Margins Hit 82% - The Globe and Mail
Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal
What a $22 Million Bet on STAAR Surgical Signals After Third-Quarter Earnings and a 15% Market Lag - The Motley Fool
STAAR Surgical’s special meeting postponed again amid shareholder opposition By Investing.com - Investing.com Nigeria
STAAR Shareholder Vote Delayed for Fourth Time - Medical Device and Diagnostic industry
Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for - Investing.com Australia
STAAR Surgical’s special meeting postponed again amid shareholder opposition - Investing.com
STAAR Surgical (STAA) Rises Amid Adjourned Shareholder Vote on A - GuruFocus
Big STAAR shareholder fights yet another delay on sale to Alcon - Stock Titan
Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal
Alcon Exercises Right To Require STAAR Surgical To Adjourn Its Special Meeting Of Stockholders - TradingView — Track All Markets
Eye implant maker delays shareholder vote on merger with Alcon - Stock Titan
Using the ICL as a supplementary IOL - EyeWorld
Will STAAR Surgical Company stock reach all time highs in 2025Trade Volume Summary & High Yield Stock Recommendations - ulpravda.ru
STAAR Surgical (NASDAQ:STAA) Shares Down 5.1%What's Next? - MarketBeat
Broadwood urges STAAR Surgical shareholders to vote against Alcon transaction - MSN
Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day - Investing.com India
Defender Capital to vote against STAAR Surgical sale to Alcon By Investing.com - Investing.com Nigeria
Defender Capital to vote against STAAR Surgical sale to Alcon - Investing.com
STAAR Surgical (NASDAQ: STAA) faces Broadwood campaign against Alcon deal and for board shake-up - Stock Titan
STAAR urges stockholders to vote for Alcon merger amid proxy battle - Investing.com Nigeria
Broadwood urges shareholders to reject Alcon’s bid for STAAR - Investing.com
Broadwood urges Staar Surgical shareholders to vote against Alcon transaction - TipRanks
Big STAAR investor fights Alcon buyout, says shares should hit $50 - Stock Titan
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value | ALC Stock News - Stock Titan
Staar Surgical Co (STAA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.70%
자본화:
|
볼륨(24시간):